Skip to main content

Advertisement

SpringerLink
Log in

The impact of obesity on diabetes, hyperlipidemia and hypertension in the United States

  • Published:
Quality of Life Research Aims and scope Submit manuscript

Abstract

Objective

The prevalence of obesity and associated cardiometabolic risk factors such as diabetes, hyperlipidemia and hypertension is increasing significantly for all demographic groups.

Research design and methods

The 2000 and 2002 Medical Expenditure Panel Survey (MEPS), a nationally representative survey of the U.S. population, was used to estimate the marginal impact of obesity on health function, perception, and preferences for individuals with diabetes, hyperlipidemia, and hypertension using multivariate regression methods controlling for age, sex, race, ethnicity, education, income, insurance, smoking status, comorbidity, and proxy response. Three different instruments were used: SF-12 physical component scale (PCS-12) and mental component scale (MCS-12); EQ-5D index and visual analogue scale (VAS). Censored least absolute deviation was used for the EQ-5D and VAS (due to censoring) and ordinary least squares (OLS) was used for the PCS-12 and MCS-12.

Results

After controlling for sociodemographic characteristics, diabetes, hyperlipidemia, and hypertension were associated with significantly lower scores compared to normal weight individuals without the condition for all four instruments. Obesity significantly exacerbated this association. Controlling for comorbidity attenuated the negative association of obesity and cardiometabolic risk factors on instrument scores. In addition, scores decreased for increasing weight and number of risk factors.

Conclusions

Obesity significantly exacerbates the deleterious association between diabetes, hyperlipidemia, and hypertension, and health function, health perception, and preference-based scores in the United States.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Flegal, K. M., Carroll, M. D., Ogden, C. L., & Johnson, C. L. (2002). Prevalence and trends in obesity among US adults, 1999–2000. Journal of the American Medical Association, 288, 1723–1727. doi:10.1001/jama.288.14.1723.

    Article  PubMed  Google Scholar 

  2. Mokdad, A. H., Serdula, M. K., Dietz, W. H., Bowman, B. A., Marks, J. S., & Koplan, J. P. (1999). The spread of the obesity epidemic in the United States, 1991–1998. Journal of the American Medical Association, 282, 1519–1522. doi:10.1001/jama.282.16.1519.

    Article  PubMed  CAS  Google Scholar 

  3. Bonow, R. O., Smaha, L. A., Smith, S. C., Jr., Mensah, G. A., & Lenfant, C. (2002). World Heart Day 2002: The international burden of cardiovascular disease: responding to the emerging global epidemic. Circulation, 106, 1602–1605. doi:10.1161/01.CIR.0000035036.22612.2B.

    Article  PubMed  Google Scholar 

  4. Greenlund, K. J., Zheng, Z. J., Keenan, N. L., et al. (2004). Trends in self-reported multiple cardiovascular disease risk factors among adults in the United States, 1991–1999. Archives of Internal Medicine, 164, 181–188. doi:10.1001/archinte.164.2.181.

    Article  PubMed  Google Scholar 

  5. American Heart Association. 2005. Heart Disease and Stroke Statistics—2005 Update. Dallas, TX: American Heart Association.

  6. Kahn, R., Buse, J., Ferrannini, E., & Stern, M. (2005). The metabolic syndrome: Time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care, 28, 2289–2304. doi:10.2337/diacare.28.9.2289.

    Article  PubMed  Google Scholar 

  7. Ford, E. S. (2005). Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: A summary of the evidence. Diabetes Care, 28, 1769–1778. doi:10.2337/diacare.28.7.1769.

    Article  PubMed  Google Scholar 

  8. Jia, H., & Lubetkin, E. I. (2005). The impact of obesity on health-related quality-of-life in the general adult US population. Journal of Public Health (Oxford, England), 27, 156–164. doi:10.1093/pubmed/fdi025.

    Article  Google Scholar 

  9. Katz, D. A., McHorney, C. A., & Atkinson, R. L. (2000). Impact of obesity on health-related quality of life in patients with chronic illness. Journal of General Internal Medicine, 15, 789–796. doi:10.1046/j.1525-1497.2000.90906.x.

    Article  PubMed  CAS  Google Scholar 

  10. Sullivan, P. W., & Ghushchyan, V. (2006). Preference-Based EQ-5D index scores for chronic conditions in the United States. Medical Decision Making, 26, 410–420. doi:10.1177/0272989X06290495.

    Article  PubMed  Google Scholar 

  11. Sullivan, P. W., Lawrence, W. F., Jr., & Ghushchyan, V. (2005). A national catalogue of preference-based scores for chronic conditions in the US. Medical Care, 43, 736–749. doi:10.1097/01.mlr.0000172050.67085.4f.

    Article  PubMed  Google Scholar 

  12. Sach, T. H., Barton, G. R., Doherty M., Muir K. R., Jenkinson C., & Avery A. J. (2006). The relationship between body mass index and health-related quality of life: comparing the EQ-5D, EuroQol VAS and SF-6D. International Journal of Obesity, 31, 189-196. doi:10.1038/sj.ijo.0803365

    Article  Google Scholar 

  13. Clarke, P., Gray, A., & Holman, R. (2002). Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62). Medical Decision Making, 22, 340–349. doi:10.1177/027298902400448902.

    Article  PubMed  Google Scholar 

  14. Roca-Cusachs, A., Dalfo, A., Badia, X., Aristegui, I., & Roset, M. (2001). Relation between clinical and therapeutic variables and quality of life in hypertension. Journal of Hypertension, 19, 1913–1919. doi:10.1097/00004872-200110000-00028.

    Article  PubMed  CAS  Google Scholar 

  15. Erickson, S. R., Williams, B. C., & Gruppen, L. D. (2004). Relationship between symptoms and health-related quality of life in patients treated for hypertension. Pharmacotherapy, 24, 344–350. doi:10.1592/phco.24.4.344.33177.

    Article  PubMed  Google Scholar 

  16. Lalonde, L., Clarke, A. E., Joseph, L., Mackenzie, T., & Grover, S. A. (1999). Comparing the psychometric properties of preference-based and nonpreference-based health-related quality of life in coronary heart disease Canadian Collaborative Cardiac Assessment Group. Quality of Life Research, 8, 399–409. doi:10.1023/A:1008991816278.

    Article  PubMed  CAS  Google Scholar 

  17. Sullivan, P. W., Ghushchyan, V., Wyatt, H. R., Wu, E. Q., & Hill, J. O. (2007). Impact of cardiometabolic risk factor clusters on health-related quality of life in the US. Obesity (Silver Spring, Md.), 15, 511–521.

    Google Scholar 

  18. Heo, M., Allison, D. B., Faith, M. S., Zhu, S., & Fontaine, K. R. (2003). Obesity and quality of life: mediating effects of pain and comorbidities. Obesity Research, 11, 209–216. doi:10.1038/oby.2003.33.

    Article  PubMed  Google Scholar 

  19. Chambers, B. A., Guo, S. S., Siervogel, R., Hall, G., & Chumlea, W. C. (2002). Cumulative effects of cardiovascular disease risk factors on quality of life. The Journal of Nutrition Health & Aging, 6, 179–184.

    CAS  Google Scholar 

  20. Documentation Files, P.U.F. Agency for Healthcare Research and Quality (AHRQ). (2005). Accessed April 28, 2006, at http://www.meps.ahrq.gov/PUFFiles/H60/H60doc.htm.

  21. Panel 7 Longitudinal Weight Files. Agency for Healthcare Research and Quality (AHRQ), (2005). Accessed November 10, 2003, at http://www.meps.ahrq.gov/PUFFiles/H80/H80doc.htm.

  22. http://www.stata.com/stb/stb58.

  23. Guyatt, G. H., Osoba, D., Wu, A. W., Wyrwich, K. W., & Norman, G. R. (2002). Methods to explain the clinical significance of health status measures. Mayo Clinic Proceedings, 77, 371–383.

    Article  PubMed  Google Scholar 

  24. Hays, R. D., & Morales, L. S. (2001). The RAND-36 measure of health-related quality of life. Annals of Medicine, 33, 350–357. doi:10.3109/07853890109002089.

    Article  PubMed  CAS  Google Scholar 

  25. Walters, S. J., & Brazier, J. E. (2003). What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D. Health and Quality of Life Outcomes, 1, 4. doi:10.1186/1477-7525-1-4.

    Article  PubMed  Google Scholar 

  26. Grootendorst, P., Feeny, D., & Furlong, W. (2000). Health Utilities Index Mark 3: Evidence of construct validity for stroke and arthritis in a population health survey. Medical Care, 38, 290–299. doi:10.1097/00005650-200003000-00006.

    Article  PubMed  CAS  Google Scholar 

  27. Lawrence, W. F., Fryback, D. G., Martin, P. A., Klein, R., & Klein, B. E. (1996). Health status and hypertension: a population-based study. Journal of Clinical Epidemiology, 49, 1239–1245. doi:10.1016/S0895-4356(96)00220-X.

    Article  PubMed  CAS  Google Scholar 

  28. Lalonde, L., O’Connor, A., Joseph, L., & Grover, S. A. (2004). Health-related quality of life in cardiac patients with dyslipidemia and hypertension. Quality of Life Research, 13, 793–804. doi:10.1023/B:QURE.0000021695.26201.a0.

    Article  PubMed  Google Scholar 

  29. Schlenk, E. A., Erlen, J. A., Dunbar-Jacob, J., et al. (1998). Health-related quality of life in chronic disorders: A comparison across studies using the MOS SF-36. Quality of Life Research, 7, 57–65. doi:10.1023/A:1008836922089.

    Article  PubMed  CAS  Google Scholar 

  30. Wee, H. L., Cheung, Y. B., Li, S. C., Fong, K. Y., & Thumboo, J. (2005). The impact of diabetes mellitus and other chronic medical conditions on health-related Quality of Life: Is the whole greater than the sum of its parts? Health and Quality of Life Outcomes, 3, 2. doi:10.1186/1477-7525-3-2.

    Article  PubMed  Google Scholar 

  31. Edwards, D. S., Winn, D. M., & Kuriantzik, V. (1994). Evaluation of the National Health Interview Survey diagnostic reporting. Hyattsville: National Center for Health Statistics; Report No. 2:1.

  32. Palta, M., Prineas, R. J., Berman, R., & Hannan, P. (1982). Comparison of self-reported and measured height and weight. American Journal of Epidemiology, 115, 223–230.

    PubMed  CAS  Google Scholar 

  33. Rowland, M. L. (1990). Self-reported weight and height. The American Journal of Clinical Nutrition, 52, 1125–1133.

    PubMed  CAS  Google Scholar 

  34. Centers for Disease Control and Prevention. (2002). National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the U.S., 2000. Atlanta: Department of Health and Human Services, Centers for Disease Control and Prevention.

Download references

Acknowledgement

This research was supported by a research grant from Sanofi-Aventis.

Author information

Authors and Affiliations

  1. Pharmaceutical Outcomes Research Program, School of Pharmacy, University of at Denver Colorado and Health Sciences Center, 4200 East Ninth Avenue, C238, Denver, CO, 80262, USA

    Patrick W. Sullivan & Vahram H. Ghushchyan

  2. Sanofi-Aventis, Bridgewater, NJ, USA

    Rami Ben-Joseph

Authors
  1. Patrick W. Sullivan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vahram H. Ghushchyan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rami Ben-Joseph
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Patrick W. Sullivan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sullivan, P.W., Ghushchyan, V.H. & Ben-Joseph, R. The impact of obesity on diabetes, hyperlipidemia and hypertension in the United States. Qual Life Res 17, 1063–1071 (2008). https://doi.org/10.1007/s11136-008-9385-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11136-008-9385-7

Keywords

Search

Navigation